This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Angela Man
Hybio Pharmaceutical における Global Business Development
スピーカー

プロフィール

Angela Man is responsible for Global CRDMO Services at Hybio Pharmaceutical, focusing on international business development and partnerships in TIDES drug development and manufacturing. She brings over 10 years of experience across the pharmaceutical and life science industry in China and Europe, with previous roles at Roche, Novartis, AstraZeneca, IMS management consulting and other global organizations. Angela has deep expertise in cross-border project management, business development, and supporting drug programs from early development through commercialization. She holds a master's degree in Bioentrepreneurship from Karolinska Institutet and is fluent in Mandarin and English.

アジェンダセッション

  • From Molecule to Market: An Integrated CRDMO Approach for Peptides

    10:35am